New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For AHS;CMCSA;GRPN;MOH;NNA;PM;PL;UTIW;WU;PRO;IRWD;ZMH;MDU;BPL From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
<< 1 | 2 | 3 | all recent news | >>
October 24, 2014
15:20 EDTGRPNGroupon weekly volatility elevated into Q3 and outlook
Subscribe for More Information
09:01 EDTGRPNGroupon launches Taste of Groupon
Subscribe for More Information
October 23, 2014
12:20 EDTCMCSAOn The Fly: Midday Wrap
Subscribe for More Information
11:13 EDTZMHZimmer price target raised to $150 from $125 at Brean Capital
Subscribe for More Information
09:04 EDTCMCSAOn The Fly: Pre-market Movers
Subscribe for More Information
08:59 EDTZMHZimmer expects capital spend to reduce significantly in 2015, going into 2016
08:33 EDTZMHZimmer 'very pleased' with integration planning with Biomet combination
The company is all on track, if not ahead of schedule. The tone of the integration is especially pleasing to the company. The company expects the closing to occur sometime in Q1, though it is not clear whether it will be in the beginning or the end of the quarter.
08:24 EDTZMHZimmer expects accretion from Biomet merger applies to 12 months after closing
Subscribe for More Information
08:23 EDTZMHZimmer: Q4 will experience seasonally lower expense ratios
08:23 EDTZMHZimmer reports FY14 gross margin ratio to be 73%-74%
Subscribe for More Information
07:53 EDTCMCSAAlibaba CEO ups Hollywood content pursuit with studio meetings, Bloomberg says
Subscribe for More Information
07:32 EDTZMHZimmer raises FY14 adjusted EPS to $6.05 from $6.00-$6.10, consensus $6.04
Subscribe for More Information
07:30 EDTZMHZimmer reports Q3 adjusted EPS $1.35, consensus $1.30
Subscribe for More Information
07:03 EDTCMCSAComcast says video customer net losses declined to 81,000 in Q3
Subscribe for More Information
07:01 EDTCMCSAComcast reports Q3 adjusted EPS 73c, consensus 71c
Reports Q3 revenue $16.8B, consensus $16.82B.
October 22, 2014
15:37 EDTCMCSA, ZMHNotable companies reporting before tomorrow's open
Notable companies reporting before tomorrow's market open, with earnings consensus, include Comcast (CMCSA), consensus 71c; Union Pacific (UNP), consensus $1.52; 3M (MMM), consensus $1.96; AbbVie (ABBV), consensus 77c; Celgene (CELG), consensus 95c; Eli Lilly (LLY), consensus 67c; Occidental Petroleum (OXY), consensus $1.57; Caterpillar (CAT), consensus $1.36; Alexion Pharmaceuticals (ALXN), consensus $1.16; Precision Castparts (PCP), consensus $3.32; Raytheon (RTN), consensus $1.60; American Electric Power (AEP), consensus $1.02; Southwest Airlines (LUV), consensus 53c; Lorillard (LO), consensus 90c; T. Rowe Price (TROW), consensus $1.15; Mead Johnson (MJN), consensus 91c; Zimmer Holdings (ZMH), consensus $1.30; Nucor (NUE), consensus 73c; Nielsen (NLSN), consensus 65c; Prologis (PLD), consensus 46c; Sigma-Aldrich (SIAL), consensus $1.06; Under Armour (UA), consensus 40c; EQT (EQT), consensus 56c; Dr Pepper Snapple (DPS), consensus 88c; Cameron International (CAM), consensus $1.10; Coca-Cola Enterprises (CCE), consensus 89c; Quest Diagnostics (DGX), consensus $1.08; CMS Energy (CMS), consensus 41c; Airgas (ARG), consensus $1.29; PulteGroup (PHM), consensus 36c; Diamond Offshore (DO), consensus 79c; Bemis (BMS), consensus 67c.
15:28 EDTCMCSAComcast October weekly 51.5 straddle priced for 3.4% move into Q3
13:06 EDTCMCSAEarnings Preview: Comcast reporting Q3 results as Time Warner deal progressing
Comcast (CMCSA, CMCSK) is set to report third quarter earnings before the market open on Thursday, October 23, with a conference call scheduled for 8:30 am ET. Comcast is a diversified media company that operates the NBC family of networks and Universal Pictures, among other cable, internet, and voice services. On February 13, Comcast announced plans to merge with Time Warner Cable (TWC) in a deal valued at $45.2B. EXPECTATIONS: Analysts are looking for earnings per share of 71c on revenue of $16.82B, according to First Call. The consensus range for EPS is 64c-76c on revenue of $16.5B-$17.17B. LAST QUARTER: Comcast reported second quarter EPS of 75c against estimates for 72c, on revenue of $16.84B against estimates for $16.95B. TIME WARNER CABLE DEAL: On August 17, The Wall Street Journal reported that the Federal Communications Commission said that one issue it must decide as it reviewed the proposed acquisition of Time Warner Cable is whether to allow Comcast to continue Time Warner Cable's arrangement to handle programming and technology acquisitions for cable operator Bright House Networks. On August 26, Engadget reported that Netflix (NFLX) filed a formal protest against the Time Warner Cable deal, saying that the merger would result in "serious public interest harm" and that a combined cable giant would have a huge amount of leverage over it and rivals such as Hulu. Hulu is a joint venture owned by Comcast along with Disney (DIS) and 21st Century Fox (FOX,FOXA). The New York Post reported on September 8 that Discovery (DISCA) believed Comcast's takeover of Time Warner Cable would give the merged entity an unfair advantage over programmers. That same day, Reuters said a proxy statement detailed that Time Warner Cable employees would split $416M if the merger deal with Comcast did not transpire. At the Goldman Sachs Communacopia Conference on September 10, Comcast said that it has made "a lot of progress" on the shareholder approval process for the Time Warner Cable deal, but expected the agreement to be finalized in early fiscal year 2015 versus the previous guidance of late 2014. The company expects the Time Warner Cable merger to generate $1.5B in operating expense synergies. On September 16, Comcast said at the Media, Communications and Entertainment Conference that it would reveal its capital plan at the close of the Time Warner Cable deal and noted at that time that "everything was on track" regarding the merger. The Wall Street Journal reported on September 30 that the FCC pushed for media companies to submit details of their programming agreements with Comcast prior to the Time Warner Cable deal. The FCC announced three days later that it extended time for the companies to file their replies on Comcast regarding the merger. On October 8, Comcast Shareholders approved stock issuance for the Time Warner Cable deal and the next day, Time Warner Cable stockholders approved the Comcast merger deal. STREET RESEARCH: Analysts remained fairly quiet on Comcast throughout the quarter. On September 9, UBS raised its price target on Comcast to $72 from $60 given its strong underlying fundamentals and the expected free cash flow accretion from the Time Warner Cable deal. The firm also said it expected Comcast to accelerate its stock buyback and increase its dividend. UBS kept its Buy rating on the stock. On October 17, Goldman Sachs said that Comcast was its top large cap pick into the earnings report given steady fundamentals, moderated expectations, and valuation. The firm maintained the stock with a Buy rating and a $64 price target. PRICE ACTION: Since the first day of trade following its Q2 report on July 22, shares of Comcast are down about 3.5%. Since it announced its deal with Time Warner Cable on February 13, shares of the media company have fallen just under 6%. In late-morning trade ahead of tomorrow’s Q3 report, shares of Comcast are down fractionally.
11:12 EDTCMCSAFCC stops 'informal clock' for review of AT&T, Comcast proposed deals
Federal Communications Commission disclosed in a notice on its website that a number of commenters filed a motion for an extension of time to file replies in Docket 14-57, which is the review of the application of Comcast (CMCSA) for approval of its proposed acquisition of Time Warner Cable (TWC). Among other points, the commenters argue that certain third-party programmers “do not want any of the interested parties’ outside counsel or experts to view [their programming contracts],” the FCC noted. "We agree with these commenters that their current inability to review Highly Confidential Information that has been submitted in these dockets significantly hampers their ability to meaningfully comment and participate in these proceedings, in both Docket 14-57 and Docket 14-90. Accordingly, we are suspending the pleading cycles and stopping our 180-day informal time clock in both dockets," the FCC stated. Docket 14-90 refers to AT&T's (T) proposed purchase of DIRECTV (DTV). Reference Link
10:09 EDTGRPNOn The Fly: Analyst Initiation Summary
Subscribe for More Information
09:12 EDTCMCSAComcast should be owned into Q3 results, says Pacific Crest
Pacific Crest expects Comcast's video subscriber trends to improve in Q3, and the firm thinks the company's video business could surpass expectations by gaining share over the next two years. Pacific Crest keeps a $65 price target and Outperform rating on the name.
October 21, 2014
17:25 EDTGRPNGroupon initiated with a Buy at Brean Capital
Subscribe for More Information
06:30 EDTPMPhilip Morris implied volatility of 15 at lower end of index mean range
October 20, 2014
16:14 EDTGRPNGroupon updates IPhone app to include Apple Pay
Subscribe for More Information
08:08 EDTIRWDIronwood presents IW-9179 Phase IIa clinical study data
Subscribe for More Information
October 17, 2014
09:59 EDTCMCSAComcast volatility elevated into Q3 and outlook
Subscribe for More Information
09:29 EDTCMCSAComcast it top large cap pick into the print, says Goldman
Goldman said Comcast is its top large cap pick into the earnings report given steady fundamentals, moderated expectations, and valuation. Shares are Buy rated with a $64 price target.
08:00 EDTCMCSAHBO may have fight with cable operators over OTT service price, Reuters says
Subscribe for More Information
October 16, 2014
15:10 EDTIRWDAmerican College of Gastroenterology to hold annual meeting
ACG Annual Scientific Meeting 2014 to be held in Philadlephia, PA on October 17-22.
08:02 EDTIRWDIronwood announces initiation of Phase II linaclotide trial
Ironwood Pharmaceuticals (IRWD) announced the initiation of a Phase II clinical trial evaluating linaclotide for the treatment of adults suffering from opioid-induced constipation. Data are expected in the second half of 2015. The clinical trial is being conducted jointly by Ironwood and Actavis plc (ACT), Ironwood’s co-development and co-promotion partner for linaclotide in the United States. Linaclotide is a guanylate cyclase-C agonist approved by the FDA for the treatment of adults with irritable bowel syndrome with constipation or chronic idiopathic constipation. Linaclotide is not currently approved for the treatment of OIC. The randomized, double-blind, placebo-controlled, multi-site Phase II clinical trial is expected to enroll approximately 240 adult patients with chronic, non-cancer pain who have been receiving a stable dose of an opioid analgesic and suffer from constipation, defined as fewer than three spontaneous bowel movements per week. Patients will be randomized to receive 145 mcg of linaclotide, 290 mcg of linaclotide, or placebo for eight weeks. The primary endpoint of the trial is an increase in SBM frequency. Additionally, a number of secondary endpoints and exploratory analyses intended to inform future development plans are included in the study design.
07:07 EDTPMPhilip Morris narrows 2014 adjusted EPS growth outlook to 6.5%-7.5%
Subscribe for More Information
07:04 EDTPMPhilip Morris reports adjusted Q3 EPS $1.39, consensus $1.33
Subscribe for More Information
October 15, 2014
16:00 EDTCMCSAOptions Update; October 15, 2014
Subscribe for More Information
15:28 EDTPMNotable companies reporting before tomorrow's open
Subscribe for More Information
07:27 EDTMOHModern Healthcare to hold a virtual conference
Building Tomorrow's Delivery Model: Forging a Path to Value is being held on October 15 at 9:30 am. Webcast Link
October 14, 2014
16:08 EDTMDUAvista 'quietly' seeks buyer, Berkshire interested, TheDeal.com says
Subscribe for More Information
14:01 EDTPMPhilip Morris October volatility elevated into Q3 and guidance
Subscribe for More Information
12:33 EDTZMHZimmer, Stryker have postive read-through from J&J, says Wells Fargo
Subscribe for More Information
11:11 EDTZMHJohnson & Johnson Ortho strength positive for Zimmer, says Piper Jaffray
Piper Jaffray said Johnson & Johnson's (JNJ) sequential Q3 strength in orthopedics, which included acceleration in both hips and knees, was surprising and a positive for Zimmer (ZMH). However, Piper expect sentiments on ortho names to remain muted until further into reporting season, noting that Stryker (SYK) is scheduled to report Thursday after the close. The firm has Neutral rating on Johnson & Johnson and Stryker and an Overweight rating on Zimmer.
October 13, 2014
06:32 EDTCMCSAUniversal receives approval to open $3.27B theme park in Beijing, WSJ reports
Subscribe for More Information
October 12, 2014
15:54 EDTCMCSA21st Century Fox's 'Gone Girl' wins at box office with $26.8M, Bloomberg says
21st Century Fox's (FOX, FOXA) “Gone Girl” took first place at the box office this weekend taking in $26.8M, says Bloomberg. "Dracula Untold,” from Comcast's (CMCSA) Universal Pictures came in second this weekend taking in $23.5M, added Bloomberg. Reference Link
<< 1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use